Fulminant hepatic failure after the start of an efavirenz-based HAART regimen in a treatment-naive female AIDS patient without hepatitis virus co-infection

被引：25

作者：

Abrescia, N ^{[1
]}

D'Abbraccio, M ^{[1
]}

Figoni, M ^{[1
]}

Busto, A ^{[1
]}

Butrico, E ^{[1
]}

De Marco, M ^{[1
]}

Viglietti, R ^{[1
]}

机构：

[1] AO D Cotugno Reg Hosp, Ctr Infect Dis, Div Infect Dis 4, I-80131 Naples, Italy

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 50卷 / 05期

关键词：

HAART hepatotoxicity; AIDS; fulminant toxic hepatitis; antiretrovirals; AIDS in women;

D O I：

10.1093/jac/dkf204

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Fulminant hepatic failure after the start of an efavirenz-based HAART regimen in a treatment-naive female AIDS patient without hepatitis virus co-infection.

引用

页码：763 / 764

页数：2

共 10 条

[1]

BARTLETT J, 2001, 8 C RETR OPP INF CHI, P48

[2] Immune reconstitution syndromes in human immunodeficiency virus infection following effective antiretroviral therapy [J].

Behrens, GMN ;

Meyer, D ;

Stoll, M ;

Schmidt, RE .

IMMUNOBIOLOGY, 2000, 202 (02) :186-193

[3]

DARMINIOMONFORT.A, 2001, J ACQ IMMUN DEF SYND, V28, P114

[4] Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection [J].

den Brinker, M ;

Wit, FWNM ;

Wertheim-van Dillen, PME ;

Jurriaans, S ;

Weel, J ;

van Leeuwen, R ;

Pakker, NG ;

Reiss, P ;

Danner, SA ;

Weverling, GJ ;

Lange, JMA .

AIDS, 2000, 14 (18) :2895-2902

[5] Hepatotoxicity with antiretroviral treatment of pregnant women [J].

Hill, JB ;

Sheffield, JS ;

Zeeman, GG ;

Wendel, GD .

OBSTETRICS AND GYNECOLOGY, 2001, 98 (05) :909-911

[6] Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy [J].

Martínez, E ;

Blanco, JL ;

Arnaiz, JA ;

Pérez-Cuevas, JB ;

Mocroft, A ;

Cruceta, A ;

Marcos, MA ;

Milinkovic, A ;

García-Viejo, MA ;

Mallolas, J ;

Carné, X ;

Phillips, A ;

Gatell, JM .

AIDS, 2001, 15 (10) :1261-1268

[7]

Moyle G J, 1999, Expert Opin Investig Drugs, V8, P473, DOI 10.1517/13543784.8.4.473

[8]

REISLER R, 2001, 1 IAS C HIV PATH TRE, P94

[9] Hepatotoxicity after introduction of highly active antiretroviral therapy [J].

Rodríguez-Rosado, R ;

García-Samaniego, J ;

Soriano, V .

AIDS, 1998, 12 (10) :1256-1256

[10] Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection [J].

Sulkowski, MS ;

Thomas, DL ;

Chaisson, RE ;

Moore, RD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (01) :74-80

← 1 →